Borderline ovarian tumours

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 3, 2012, Pages 325-336

  Tropé, Claes Göran ^a,b   Kaern, Janne ^a   Davidson, Ben ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

borderline ovarian tumours; clinical outcome; epidemiology; fertility; management; prognostic factors; surgery

Indexed keywords

ARTICLE; BORDERLINE OVARY TUMOR; CONSERVATIVE TREATMENT; FEMALE FERTILITY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LAPAROSCOPIC SURGERY; OVARY TUMOR; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCTIVE PROCEDURES; SURGICAL TECHNIQUE; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR RECURRENCE;

CARCINOMA; FEMALE; FERTILITY PRESERVATION; HUMANS; HYSTERECTOMY; INFERTILITY, FEMALE; NEOPLASM STAGING; ORGAN SPARING TREATMENTS; OVARIAN NEOPLASMS; OVARIECTOMY; SALPINGECTOMY;

EID: 84860222463     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2011.12.006     Document Type: Article

References (87)

1. H.C. Taylor Malignant and semi-malignant tumors of the ovary Surg Gynecol Obstet 48 1929 204 230
2. Kottmeier HL, Kolstad P, McGarrity KA. Annual report on results of treatment in gynaecologic cancer, vol. 17. Statements of results obtained in 1969-1972, inclusive. FIGO. Stockholm, Sweden, Editorial office, Radiumhemmet, 1973.
3. S.F. Serov, R.E. Scully, and L.H. Sobin International histological classification of tumors, no 9. Histoloigcal typing of ovarian tumours 1973 Geneval: World Health Organization
4. W.R. Hart, and H.J. Norris Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior Cancer 31 1973 1031 1045
5. R.E. Scully Tumors of the ovary and maldeveloped gonads Fascicle 16 Atlas of tumor pathology. Second series 1979 Armed Forces Institute of Pathology Washington DC 75 90
6. M.S. Lenhard, S. Mitterer, and C. Kümper Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort Eur J Obstet Gynecol Reprod Biol 145 2009 189 194
7. J.T. Quirk, and N. Natarajan Ovarian cancer incidence in the United States, 1992-1999 Gynecol Oncol 97 2005 519 523 (Pubitemid 40614898)
8. J. Kaern, C.G. Tropé, and V.M. Abeler A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities Cancer 71 1993 1810 1820 (Pubitemid 23067398)
9. T. Bjørge, A. Engeland, and S. Hansen Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993 Int J Cancer 71 1997 780 786 (Pubitemid 27237199)
10. I. Skírnisdóttir, H. Garmo, and E. Wilander Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer Int J Cancer 123 2008 1897 1901
11. F. Trillsch, S. Mahner, and J. Ruetzel Clinical management of borderline ovarian tumors Expert Rev Anticancer Ther 10 2010 1115 1124
12. M.E. Sherman, P.J. Mink, and R. Curtis Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis Cancer 100 2004 1045 1052 (Pubitemid 38222865)
13. Kramer JL, Greene MH. Epidemiology of ovarian, fallopian tube, and primary peritoneal cancer. In: Gershenson DM, McGuire WP, Gore M, et al., eds Gynecologic cancer. Controversies in management, 1st ed. Philadelphia: Elsevier Churchill Livingstone; 2004, pp. 327-340.
14. C. Tropé, B. Davidson, and T. Paulsen Diagnosis and treatment of borderline ovarian neoplasms 'the state of the art' Eur J Gynaecol Oncol 30 2009 471 482
15. R.J. Kurman, and IeM Shih Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 2008 151 160 (Pubitemid 351450677)
16. R.J. Kurman, K. Visvanathan, and R. Roden Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis Am J Obstet Gynecol 198 2008 351 356 (Pubitemid 351451941)
17. IeM Shih, and R.J. Kurman Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis Am J Pathol 164 2004 1511 1518 (Pubitemid 38529752)
18. K. Levanon, C. Crum, and R. Drapkin New insights into the pathogenesis of serous ovarian cancer and its clinical impact J Clin Oncol 26 2008 5284 5293
19. I. Meinhold-Heerlein, D. Bauerschlag, and F. Hilpert Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential Oncogene 24 2005 1053 1065 (Pubitemid 40313882)
20. T. Bonome, J.Y. Lee, and D.C. Park Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary Cancer Res 65 2005 10602 10612 (Pubitemid 41743756)
21. S. Mahner, C. Baasch, and J. Schwarz C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma Br J Cancer 99 2008 1269 1275
22. B.H. Ortiz, M. Ailawadi, and C. Colitti Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors Cancer Res 61 2001 7264 7267 (Pubitemid 32946524)
23. K.R. Lee, F.A. Tavassoli, and J. Prat Tumours of the ovary and peritoneum F.A. Tavassoli, P. Devilee, Pathology and genetics. Tumours of the breast and female genital organs 2003 IARC Press Lyon 113 202
24. Oedegaard E. Ovarian carcinomas and borderline ovarian tumors - molecular markers and operative treatment. Dissertation, Facutly of Medicine, University of Oslo, 2008.
25. S.C. Mok, D.A. Bell, and R.C. Knapp Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy Cancer Res 53 1993 1489 1492 (Pubitemid 23113216)
26. A. du Bois, N. Ewald-Riegler, and O. du Bois Borderline tumors of the ovary: a systematic review [German] Geburtsh Frauenheilk 69 2009 807 833
27. J.D. Seidman, I. Horkayne-Szakaly, and M. Haiba The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin Int J Gynecol Pathol 23 2004 41 44 (Pubitemid 38018236)
28. J. Prat, and M. De Nictolis Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion Am J Surg Pathol 26 2002 1111 1128 (Pubitemid 34969181)
29. D.A. Bell, M.A. Weinstock, and R.E. Scully Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis Cancer 62 1988 2212 2222 (Pubitemid 18261863)
30. R. Tinelli, A. Tinelli, and F.G. Tinelli Conservative surgery for borderline ovarian tumors: a review Gynecol Oncol 100 2006 185 191 (Pubitemid 41815071)
31. R.J. Kurman, and C.L. Trimble The behavior of serous tumors of low malignant potential: are they ever malignant? Int J Gynecol Pathol 12 1993 120 127 (Pubitemid 23095184)
32. P. Morice, S. Camatte, and A. Rey Prognostic factors for patients with advanced stage serous borderline tumours of the ovary Ann Oncol 14 2003 592 598 (Pubitemid 41295089)
33. R.F. Bradley, J.H. Stewart 4th, and G.B. Russell Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review Am J Surg Pathol 30 2006 551 559 (Pubitemid 44265007)
34. E.G. Silva, D.M. Gershenson, and A. Malpica The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent Am J Surg Pathol 30 2006 1367 1371 (Pubitemid 44655469)
35. J.D. Seidman, and R.J. Kurman Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators Hum Pathol 31 2000 539 557 (Pubitemid 30323979)
36. S.J. Chang, H.S. Ryu, and K.H. Chang Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors Acta Obstet Gynecol Scand 87 2008 476 481
37. H. Fox, and M. Wells Surface epithelialstromal tumors of the ovary H. Fox, M. Wells, Haines and Taylor. Obstetrical and Gynaecological Pathology 5th ed. 2003 Churchill Livingstone London 713 743
38. J. Ren, Z. Peng, and K. Yang A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors Gynecol Oncol 110 2008 162 167
39. T.A. Longacre, J.K. McKenney, and H.D. Tazelaar Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up Am J Surg Pathol 29 2005 707 723 (Pubitemid 40734421)
40. M. Cusidó, L. Balagueró, and G. Hernandez Results of the national survey of borderline ovarian tumors in Spain Gynecol Oncol 104 2007 617 622 (Pubitemid 46240250)
41. J. Kaern, C.G. Tropé, and G.B. Kristensen DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary Int J Gynecol Cancer 3 1993 349 358 (Pubitemid 23336312)
42. J.S. Meyer, D.J. Gersell, and S. Yim Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate Gynecol Oncol 81 2001 466 476 (Pubitemid 32494664)
43. M.B. Verbruggen, P.J. van Diest, and J.P. Baak The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study Int J Gynecol Pathol 28 2009 35 40
44. Y. Yokoyama, T. Moriya, and T. Takano Clinical outcome and risk factors for recurrence in borderline ovarian tumours Br J Cancer 94 2006 1586 1591 (Pubitemid 43924918)
45. J.F. Leake, J.S. Rader, and J.D. Woodruff Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential Gynecol Oncol 42 1991 124 130
46. T. Paulsen, J. Kaern, and K. Kjaerheim Symptoms and referral of women with epithelial ovarian tumors Int J Gynaecol Obstet 88 2005 31 37 (Pubitemid 40023091)
47. Paulsen T. Epithelial ovarian cancer. A clinical epidemiological approach on diagnosis and treatment. Dissertation, Faculty of Medicine, University of Oslo, 2007.
48. C.G. Tropé, G. Kristensen, and A. Makar Surgery for borderline tumor of the ovary Semin Surg Oncol 19 2000 69 75 (Pubitemid 30439318)
49. C.B. Tempfer, S. Polterauer, and E.K. Bentz Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature Gynecol Oncol 107 2007 248 252 (Pubitemid 47575720)
50. S. Camatte, P. Morice, and A. Thoury Impact of surgical staging in patients with macroscopic 'stage I' ovarian borderline tumours: analysis of a continuous series of 101 cases Eur J Cancer 40 2004 1842 1849 (Pubitemid 39036758)
51. I. Cadron, K. Leunen, and T. Van Gorp Management of borderline ovarian neoplasms J Clin Oncol 25 2007 2928 2937 (Pubitemid 47123157)
52. D.D. Snider, G.C. Stuart, and J.G. Nation Evaluation of surgical staging in stage I low malignant potential ovarian tumors Gynecol Oncol 40 1991 129 132
53. B.M. Ronnett, R.J. Kurman, and C.M. Zahn Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential Hum Pathol 26 1995 509 524
54. J.D. Seidman, A.M. Elsayed, and L.H. Sobin Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases Am J Surg Pathol 17 1993 22 34 (Pubitemid 23011317)
55. E.L. Trimble, and L.C. Trimble Epithelial ovarian tumors of low malignant potential M. Markman, W. Hoskins, Cancer of the Ovary 1993 Raven Press New York 415 429
56. G. Zanetta, S. Rota, and S. Chiari Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study J Clin Oncol 19 2001 2658 2664 (Pubitemid 32441370)
57. R. Fauvet, J. Boccara, and C. Dufournet Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study Cancer 100 2004 1145 1151 (Pubitemid 38325941)
58. I. Zapardiel, P. Rosenberg, and M. Peiretti The role of restaging borderline ovarian tumors: single institution experience and review of the literature Gynecol Oncol 119 2010 274 277
59. X. Deffieux, P. Morice, and S. Camatte Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants Gynecol Oncol 97 2005 84 89 (Pubitemid 40403679)
60. R. Fauvet, J. Boccara, and C. Dufournet Laparoscopic management of borderline ovarian tumors: results of a French multicenter study Ann Oncol 16 2005 403 410 (Pubitemid 40458316)
61. I. Vandenput, F. Amant, and I. Vergote Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy Gynecol Oncol 98 2005 523
62. I. Cadron, F. Amant, and T. Van Gorp The management of borderline tumours of the ovary Curr Opin Oncol 18 2006 488 493 (Pubitemid 44199846)
63. I. Vergote, J. De Brabanter, and A. Fyles Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Lancet 357 2001 176 182 (Pubitemid 32108089)
64. D.M. Gershenson, and E.G. Silva Serous ovarian tumors of low malignant potential with peritoneal implants Cancer 65 1990 578 585 (Pubitemid 20058378)
65. D.M. Gershenson Clinical management potential tumours of low malignancy Best Pract Res Clin Obstet Gynaecol 16 2002 513 527 (Pubitemid 41123405)
66. A.P. Heintz, F. Odicino, and P. Maisonneuve Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S161 S192
67. T. Bjørge, A. Engeland, and S. Hansen Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993 Int J Cancer 75 1998 663 670 (Pubitemid 28145810)
68. J.D. Seidman, and R.J. Kurman Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases Am J Surg Pathol 20 1996 1331 1345 (Pubitemid 26367204)
69. M.E. Sherman, J. Berman, and M.J. Birrer Current challenges and opportunities for research on borderline ovarian tumors Hum Pathol 35 2004 961 970 (Pubitemid 39037179)
70. J.F. Leake, J.L. Currie, and N.B. Rosenshein Long-term follow-up of serous ovarian tumors of low malignant potential Gynecol Oncol 47 1992 150 158 (Pubitemid 23001321)
71. S.K. Lim-Tan, H.E. Cajigas, and R.E. Scully Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases Obstet Gynecol 72 1988 775 781
72. P. Morice, S. Camatte, and J. El Hassan Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors Fertil Steril 75 2001 92 96 (Pubitemid 32041230)
73. S. Camatte, P. Morice, and P. Pautier Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary BJOG 109 2002 376 380 (Pubitemid 37338013)
74. M.A. Crispens, D. Bodurka, and M. Deavers Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential Obstet Gynecol 99 2002 3 10 (Pubitemid 34075460)
75. R. Fauvet, C. Poncelet, and J. Boccara Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study Fertil Steril 83 2005 284 290 (Pubitemid 40221778)
76. R.T. Morris, D.M. Gershenson, and E.G. Silva Outcome and reproductive function after conservative surgery for borderline ovarian tumors Obstet Gynecol 95 2000 541 547 (Pubitemid 30139573)
77. W.H. Gotlieb, S. Flikker, and B. Davidson Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome Cancer 82 1998 141 146 (Pubitemid 28070490)
78. T. Maltaris, D. Boehm, and R. Dittrich Reproduction beyond cancer: a message of hope for young women Gynecol Oncol 103 2006 1109 1121 (Pubitemid 44821345)
79. M.E. Beiner, W.H. Gotlieb, and B. Davidson Infertility treatment after conservative management of borderline ovarian tumors Cancer 92 2001 320 325 (Pubitemid 32664437)
80. S.J. Fasouliotis, O. Davis, and G. Schattman Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report Fertil Steril 82 2004 568 572 (Pubitemid 39243175)
81. S. Kashyap, and O.K. Davis Ovarian cancer and fertility medications: a critical appraisal Semin Reprod Med 21 2003 65 71 (Pubitemid 36676155)
82. P. Morice, S. Camatte, and F. Wicart-Poque Results of conservative management of epithelial malignant and borderline ovarian tumours Hum Reprod Update 9 2003 185 192 (Pubitemid 36582606)
83. A.S. Whittemore, R. Harris, and J. Itnyre Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group Am J Epidemiol 136 1992 1184 1203 (Pubitemid 23026890)
84. A. Fortin, P. Morice, and A. Thoury Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study Fertil Steril 87 2007 591 596 (Pubitemid 46385955)
85. C.W. Burger, A. van de Swaluw, and T.M. Mooij Risk of borderline and invasive ovarian tumors after ovarian stimulation for in vitro fertilization in a large Dutch cohort after 15 years of follow-up. Abstracts presented for the 40th Annual Meeting of the Society of Gynecologic Oncologists February 2009 (abstract no 6) Gynecol Oncol 112 Suppl. 2009 S4
86. J. Donnez, M.M. Dolmans, and D. Demylle Livebirth after orthotopic transplantation of cryopreserved ovarian tissue Lancet 364 2004 1405 1410 (Pubitemid 39370715)
87. D.M. Lee, R.R. Yeoman, and D.E. Battaglia Live birth after ovarian tissue transplant Nature 428 2004 137 138 (Pubitemid 38374297)